Craig-Hallum Initiates Coverage of Adaptive Biotechnologies (ADPT) stock, Gives Buy

By Yahoo! Finance   |   1 week ago
Craig-Hallum Initiates Coverage of Adaptive Biotechnologies (ADPT) stock, Gives Buy

Adaptive Biotechnologies Corporation is a leader in testing for minimal residual disease in patients with hematologic malignancies, with growth potential and strong near-term drivers. Craig-Hallum rates the stock a "Buy" with a price target of $15.

Read More

Did you find this insightful?